Egg consumption as part of an energy-restricted high-protein diet improves blood lipid and blood glucose profiles in individuals with type 2 diabetes

British Journal of Nutrition

Volumn 105, Issue 4, 2011, Pages 584-592

  Pearce, Karma L ^a,b,c   Clifton, Peter M ^a   Noakes, Manny ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Blood glucose; Eggs; Lipid profiles; Type 2 diabetes; Weight reducing diets

Indexed keywords

APOLIPOPROTEIN B; FOLIC ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; TRIACYLGLYCEROL; XANTHOPHYLL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CALORIC RESTRICTION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; EGG; FEMALE; FOLIC ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; LUTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADULT; AGED; APOLIPOPROTEINS B; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CALORIC RESTRICTION; CARBOHYDRATES; DIABETES MELLITUS, TYPE 2; DIET; DIETARY PROTEINS; EGGS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LIPIDS; MALE; MIDDLE AGED;

ANIMALIA;

EID: 79951678316     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510003983     Document Type: Article

References (46)

1. Dunstan D, Zimmet P, Welborn T, et al. (2002) The rising preverlence of diabetes and impared glucose tolerance: The Australian Diabetes and Lifestlye Study. Diabetes Care 28, 829-834. (Pubitemid 41094278)
2. Haffner SM (1998) Epidemiology of type 2 diabetes: risk factors. Diabetes Care 21, Suppl. 3, C3-C6. (Pubitemid 28545942)
3. Marks JB & Raskin P (2000) Cardiovascular risk in diabetes: a brief review. J Diabetes Complications 14, 108-115. (Pubitemid 30665761)
4. Gannon M, Nuttall FQ, Saeed A, et al. (2003) An increase in dietary protein improves blood glucose response in persons with type 2 diabetes. Am J Clin Nutr 78, 734-741. (Pubitemid 39663491)
5. Baba NH, Sawaya S, Torbay N, et al. (1999) High protein vs high carbohydrate hypoenergetic diet for the treatment of obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord 23, 1202-1206.
6. Layman DK, Boileau RA, Erickson DJ, et al. (2003) A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr 133, 411-417. (Pubitemid 36172892)
7. Piatti PM, Monti F, Fermo I, et al. (1994) Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism 43, 1481-1487. (Pubitemid 24382697)
8. Skov AR, Toubro S, Ronn B, et al. (1999) Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord 23, 528-536. (Pubitemid 29237736)
9. Hu FB, Stampfer MJ, Rimm EB, et al. (1999) A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 281, 1387-1394. (Pubitemid 29190216)
10. Tanasescu M, Cho E, Manson JE, et al. (2004) Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr 79, 999-1005. (Pubitemid 41095951)
11. Weggemans RM, Zock PL & Katan MB (2001) Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-anal-ysis. Am J Clin Nutr 73, 885-891. (Pubitemid 32405984)
12. Reaven GM (2001) Insulin resistance, dietary cholesterol, and cholesterol concentration in postmenopausal women. Metabolism 50, 594-597. (Pubitemid 32433051)
13. Romano G, Tilly-Kiesi MK, Patti L, et al. (1998) Effects of dietary cholesterol on plasma lipoproteins and their subclasses in IDDM patients. Diabetologia 41, 193-200. (Pubitemid 28088396)
14. Tannock LR, O'Brien KD, Knopp RH, et al. (2005) Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 111, 3058-3062. (Pubitemid 40847782)
15. WHO/Internation Diabetes Federation (2006) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglyce-mia: Report of a WHO/IDF Consultation. Geneva: WHO/ Internation Diabetes Federation.
16. World Health Organization (1980) World Health Organization: Expert Committee on Diabetes Mellitus. Report no. 646. Geneva: World Health Organization.
17. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
18. Wallace TM, Levy JC & Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487-1495. (Pubitemid 38680001)
19. Yang CS & Lee MJ (1987) Methodology of plasma retinol, tocopherol and carotenoid assays in cancer prevention studies. J Nutr Growth Cancer 4, 1927.
20. Khachik F, Beecher GR, Goli MB, et al. (1992) Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem 64, 2111-2122.
21. Clifton PM, Noakes M, Ross D, et al. (2004) High dietary intake of phytosterol esters decreases carotenoids and increases plasma plant sterol levels with no additional cholesterol lowering. J Lipid Res 45, 1493-1499. (Pubitemid 39006977)
22. Baecke JA, Burema J & Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36, 936-942. (Pubitemid 13214364)
23. Parker B, Noakes M, Luscombe N, et al. (2002) Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 25, 425-430. (Pubitemid 41103331)
24. Boden WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86, 19L-22L.
25. Mutungi G, Ratliff J, Puglisi M, et al. (2008) Dietary cholesterol from eggs increases plasma HDL cholesterol in overweight men consuming a carbohydrate-restricted diet. J Nutr 138, 272-276. (Pubitemid 351213638)
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285; 2486-2497.
27. Grundy SM, Wilhelmsen L, Rose G, et al. (1990) Coronary heart disease in high-risk populations: lessons from Finland. Eur Heart J 11, 462-471. (Pubitemid 20174911)
28. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389.
29. Spady DK & Dietschy JM (1988) Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest 81, 300-309. (Pubitemid 18075220)
30. Knopp RH, Retzlaff B, Fish B, et al. (2003) Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 23, 1437-1443. (Pubitemid 36994533)
31. Herron KL, Lofgren IE, Adiconis X, et al. (2006) Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis 184, 113-120. (Pubitemid 41721077)
32. Herron KL, McGrane MM, Waters D, et al. (2006) The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J Nutr 136, 1161-1165.
33. Herron KL, Vega-Lopez S, Conde K, et al. (2002) Pre-menopausal women, classified as hypo- or hyper-respon-ders, do not alter their LDL/HDL ratio following a high dietary cholesterol challenge. J Am Coll Nutr 21, 250-258. (Pubitemid 34602845)
34. Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb Vasc Biol 11, 2-14.
35. Verschuren WM, Jacobs DR, Bloemberg BP, et al. (1995) Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274, 131-136.
36. Sattar N, Williams K, Sniderman AD, et al. (2004) Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 110, 2687-2693. (Pubitemid 39453020)
37. Strandberg TE, Pyorala K, Cook TJ, et al. (2004) Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 364, 771-777. (Pubitemid 39165096)
38. Sniderman AD, Furberg CD & Keech A (2003) Apoproteins versus lipids as indices of coronary risk and as targets for statin therapy. Lancet 361, 777-780. (Pubitemid 36293636)
39. Linn S, Fulwood R, Carroll M, et al. (1991) Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). Am J Public Health 81, 1038-1043.
40. Castelli WP (1988) Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 4, Suppl. A, 5A-10A.
41. Bostom AG, Gagnon DR, Cupples LA, et al. (1994) A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 90, 1688-1695. (Pubitemid 24320915)
42. Bostom AG, Cupples LA, Jenner JL, et al. (1996) Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 276, 544-548. (Pubitemid 26272299)
43. Wing RR, Koeske R, Epstein LH, et al. (1987) Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 147, 1749-1753. (Pubitemid 17159673)
44. Ginsberg H, Plutzky J & Sobel BE (1999) A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering. J Cardiovasc Risk 6, 337-346. (Pubitemid 30025631)
45. Stamler J, Vaccaro O, Neaton JD, et al. (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16, 434-444. (Pubitemid 23046633)
46. Yancy WS Jr, Foy M, Chalecki AM, et al. (2005) A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2, 34.